Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 443

The DOI matches its Crossref record; 148 of the 148 references it cites were found in a registry or an index.

Urinary incontinence in women

Open access
Aoki, Yoshitaka, Brown, Heidi W., Brubaker, Linda, Cornu, Jean Nicolas, Daly, J. Oliver, Cartwright, Rufus·2017·Nature Reviews Disease Primers

Abstract

Urinary incontinence symptoms are highly prevalent among women, have a substantial effect on health-related quality of life and are associated with considerable personal and societal expenditure. Two main types are described: stress urinary incontinence, in which urine leaks in association with physical exertion, and urgency urinary incontinence, in which urine leaks in association with a sudden compelling desire to void. Women who experience both symptoms are considered as having mixed urinary incontinence. Research has revealed overlapping potential causes of incontinence, including dysfunction of the detrusor muscle or muscles of the pelvic floor, dysfunction of the neural controls of storage and voiding, and perturbation of the local environment within the bladder. A full diagnostic evaluation of urinary incontinence requires a medical history, physical examination, urinalysis, assessment of quality of life and, when initial treatments fail, invasive urodynamics. Interventions can include non-surgical options (such as lifestyle modifications, pelvic floor muscle training and drugs) and surgical options to support the urethra or increase bladder capacity. Future directions in research may increasingly target primary prevention through understanding of environmental and genetic risks for incontinence.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/nrdp.2017.42

Cites

148 of 148 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 49

  1. Subak, L. L. et al. High costs of urinary incontinence among women electing surgery to treat stress incontinence. Obstet. Gynecol. 111, 899–907 (2008). · doi:10.1097/aog.0b013e31816a1e12
  2. Ganz, M. L. et al. Economic costs of overactive bladder in the United States. Urology 75, 526–532.e18 (2010). · doi:10.1016/j.urology.2009.06.096
  3. Agarwal, A. et al. What is the most bothersome lower urinary tract symptom? Individual- and population-level perspectives for both men and women. Eur. Urol. 65, 1211–1217 (2014). · doi:10.1016/j.eururo.2014.01.019
  4. Helfand, B. T., Evans, R. M. & McVary, K. T. A comparison of the frequencies of medical therapies for overactive bladder in men and women: analysis of more than 7.2 million aging patients. Eur. Urol. 57, 586–591 (2010). · doi:10.1016/j.eururo.2009.12.025
  5. Milsom, I. et al. in Incontinence. 5th International Consultation on Incontinence (eds Abrams, P., Cardozo, L., Khoury, S. & Wein, A. ) 15–107 (ICUD-EAU, 2013).
  6. Gomez-Amaya, S. M., Ruggieri, M. R., Arias Serrato, S. A., Massicotte, V. S. & Barbe, M. F. Gross anatomical study of the nerve supply of genitourinary structures in female mongrel hound dogs. Anat. Histol. Embryol. 44, 118–127 (2014). · doi:10.1111/ahe.12116
  7. Hillary, C. J., Osman, N. & Chapple, C. Considerations in the modern management of stress urinary incontinence resulting from intrinsic sphincter deficiency. World J. Urol. 33, 1251–1256 (2015). · doi:10.1007/s00345-015-1599-z
  8. Roosen, A. et al. A refocus on the bladder as the originator of storage lower urinary tract symptoms: a systematic review of the latest literature. Eur. Urol. 56, 810–820 (2009). · doi:10.1016/j.eururo.2009.07.044
  9. Li, M., Sun, Y., Simard, J. M. & Chai, T. C. Increased transient receptor potential vanilloid type 1 (TRPV1) signaling in idiopathic overactive bladder urothelial cells. Neurourol. Urodyn. 30, 606–611 (2011). · doi:10.1002/nau.21045
  10. Brubaker, L. & Wolfe, A. J. Microbiota in 2016: associating infection and incontinence with the female urinary microbiota. Nat. Rev. Urol. 14, 72–74 (2017). · doi:10.1038/nrurol.2016.262
  11. Abrams, P. et al. in Incontinence. 5th International Consultation on Incontinence (eds Abrams, P., Cardozo, L., Khoury, S. & Wein, A. ) 1895–1956 (ICUD-EAU, 2013).
  12. Swift, S. E. & Yoon, E. A. Test–retest reliability of the cough stress test in the evaluation of urinary incontinence. Obstet. Gynecol. 94, 99–102 (1999).
  13. Hsu, T. H., Rackley, R. R. & Appell, R. A. The supine stress test: a simple method to detect intrinsic urethral sphincter dysfunction. J. Urol. 162, 460–463 (1999). · doi:10.1016/s0022-5347(05)68589-8
  14. Swift, S., Barnes, D., Herron, A. & Goodnight, W. Test–retest reliability of the cotton swab (Q-tip®) test in the evaluation of the incontinent female. Int. Urogynecol. J. 21, 963–967 (2010). · doi:10.1007/s00192-010-1135-z
  15. Meyer, I., Szychowski, J. M., Illston, J. D., Parden, A. M. & Richter, H. E. Vaginal swab test compared with the urethral Q-tip test for urethral mobility measurement. Obstet. Gynecol. 127, 348–352 (2016). · doi:10.1097/aog.0000000000001243
  16. Smith, A., Bevan, D., Douglas, H. R. & James, D. Management of urinary incontinence in women: summary of updated NICE guidance. BMJ 347, f5170 (2013). A good summary of the current evidence for treatments of urinary incontinence. · doi:10.1136/bmj.f5170
  17. Buchsbaum, G. M., Albushies, D. T. & Guzick, D. S. Utility of urine reagent strip in screening women with incontinence for urinary tract infection. Int. Urogynecol. J. 15, 391–393 (2004). · doi:10.1007/s00192-004-1192-2
  18. Bettez, M. et al. 2012 update: guidelines for adult urinary incontinence collaborative consensus document for the Canadian Urological Association. Can. Urol. Assoc. J. 6, 354–363 (2012). · doi:10.5489/cuaj.12248
  19. Serati, M. et al. Ultrasound measurement of bladder wall thickness in different forms of detrusor overactivity. Int. Urogynecol. J. 21, 1405–1411 (2010). · doi:10.1007/s00192-010-1194-1
  20. Bogusiewicz, M. et al. Both the middle and distal sections of the urethra may be regarded as optimal targets for ‘outside-in’ transobturator tape placement. World J. Urol. 32, 1605–1611 (2014). · doi:10.1007/s00345-014-1261-1
  21. Clement, K. D., Lapitan, M. C. M., Omar, M. I. & Glazener, C. M. A. Urodynamic studies for management of urinary incontinence in children and adults. Cochrane Database Syst. Rev. 10, CD003195 (2013).
  22. van Leijsen, S. A. L. et al. Can preoperative urodynamic investigation be omitted in women with stress urinary incontinence? A non-inferiority randomized controlled trial. Neurourol. Urodyn. 31, 1118–1123 (2012). · doi:10.1002/nau.22230
  23. Fonda, D. & Abrams, P. Cure sometimes, help always — a ‘continence paradigm’ for all ages and conditions. Neurourol. Urodyn. 25, 290–292 (2006). · doi:10.1002/nau.20187
  24. Myers, D. L. Female mixed urinary incontinence: a clinical review. JAMA 311, 2007–2014 (2014). · doi:10.1001/jama.2014.4299
  25. Morris, A. R. & Moore, K. H. The Contiform incontinence device? Efficacy and patient acceptability. Int. Urogynecol. J. Pelvic Floor Dysfunct. 14, 412–417 (2003). · doi:10.1007/s00192-003-1094-8
  26. Kubota, Y. et al. Correlation between improvements in overactive bladder symptom score and health-related quality of life questionnaires in overactive bladder patients treated with an antimuscarinic drug. Neurourol. Urodyn. 30, 1309–1314 (2011). · doi:10.1002/nau.21065
  27. Oefelein, M. G. Safety and tolerability profiles of anticholinergic agents used for the treatment of overactive bladder. Drug Saf. 34, 733–754 (2011). · doi:10.2165/11592790-000000000-00000
  28. Linnér, L., Schiöler, H., Samuelsson, E., Milsom, I. & Nilsson, F. Low persistence of anticholinergic drug use in Sweden. Eur. J. Clin. Pharmacol. 67, 535–536 (2010). · doi:10.1007/s00228-010-0917-z
  29. Reynolds, W. S. et al. Comparative effectiveness of anticholinergic therapy for overactive bladder in women: a systematic review and meta-analysis. Obstet. Gynecol. 125, 1423–1432 (2015). · doi:10.1097/aog.0000000000000851
  30. MacDiarmid, S. et al. Mirabegron as add-on treatment to solifenacin in patients with incontinent overactive bladder and an inadequate response to solifenacin monotherapy. J. Urol. 196, 809–818 (2016). · doi:10.1016/j.juro.2016.03.174
  31. Drake, M. J. et al. Efficacy and safety of mirabegron add-on therapy to solifenacin in incontinent overactive bladder patients with an inadequate response to initial 4-week solifenacin monotherapy: a randomised double-blind multicentre phase 3B study (BESIDE). Eur. Urol. 70, 136–145 (2016). · doi:10.1016/j.eururo.2016.02.030
  32. Canadian Agency for Drugs and Technologies in Health. in Common Drug Reviewhttps://www.ncbi.nlm.nih.gov/books/NBK349284/ (CADTH, 2015).
  33. Pindoria, N. et al. Persistence with mirabegron therapy for overactive bladder: a real life experience. Neurourol. Urodyn. 36, 404–408 (2015). · doi:10.1002/nau.22943
  34. Hunskaar, S. & Welle-Nilsen, L. K. The market lifecycle of duloxetine for urinary incontinence in Norway. Acta Obstet. Gynecol. Scand. 89, 217–222 (2010). · doi:10.3109/00016340903508650
  35. Abdel-Fattah, M., Cao, G. & Mostafa, A. Long-term outcomes for transobturator tension-free vaginal tapes in women with urodynamic mixed urinary incontinence. Neurourol. Urodyn. 36, 902–908 (2016). · doi:10.1002/nau.23192
  36. Leong, R. K., de Wachter, S. G. G., Joore, M. A. & van Kerrebroeck, P. E. V. Cost-effectiveness analysis of sacral neuromodulation and botulinum toxin A treatment for patients with idiopathic overactive bladder. BJU Int. 108, 558–564 (2010). · doi:10.1111/j.1464-410x.2010.09905.x
  37. Amundsen, C. L. et al. OnabotulinumtoxinA versus sacral neuromodulation on refractory urgency urinary incontinence in women. JAMA 316, 1366–1374 (2016). · doi:10.1001/jama.2016.14617
  38. Haslam, J. Urinary incontinence: why women do not ask for help. Nurs. Times 101, 47–48 (2005).
  39. Yip, S.-K. et al. The impact of urodynamic stress incontinence and detrusor overactivity on marital relationship and sexual function. Am. J. Obstet. Gynecol. 188, 1244–1248 (2003). · doi:10.1067/mob.2003.273
  40. Nygaard, I. Idiopathic urgency urinary incontinence. N. Engl. J. Med. 363, 1156–1162 (2010). · doi:10.1056/nejmcp1003849
  41. Gotoh, M. et al. Impact of urinary incontinence on the psychological burden of family caregivers. Neurourol. Urodyn. 28, 492–496 (2009). · doi:10.1002/nau.20675
  42. Kang, Y., Phillips, L. R. & Kim, S.-S. Incontinence quality of life among Korean-American women. Urol. Nurs. 30, 130–136 (2010). · doi:10.7257/1053-816x.2010.30.2.130
  43. Perez, L. M. & Webster, G. D. The history of urodynamics. Neurourol. Urodyn. 11, 1–21 (1992). · doi:10.1002/nau.1930110102
  44. Sheng, W., Zhang, H. & Ruth, K.-H. Could urinary nerve growth factor be a biomarker for overactive bladder? A meta-analysis. Neurourol. Urodyn.http://dx.doi.org/10.1002/nau.23210 (2017). · doi:10.1002/nau.23210
  45. Cartwright, R. et al. Identification of two novel genomic loci associated with stress and urgency urinary incontinence in a genome wide association study. Int. Urogynecol. J. 26, S53–S54 (2015).
  46. von Gontard, A., Heron, J. & Joinson, C. Family history of nocturnal enuresis and urinary incontinence: results from a large epidemiological study. J. Urol. 185, 2303–2307 (2011). · doi:10.1016/j.juro.2011.02.040
  47. Ferroni, M. C. et al. Role of the brain stem in tibial inhibition of the micturition reflex in cats. Am. J. Physiol. Renal Physiol. 309, F242–F250 (2015). · doi:10.1152/ajprenal.00135.2015
  48. Twiss, C. et al. Validating the Incontinence Symptom Severity Index: a self-assessment instrument for voiding symptom severity in women. J. Urol. 182, 2384–2391 (2009). · doi:10.1016/j.juro.2009.07.025
  49. Shaw, C. et al. Validity and reliability of a questionnaire to measure the impact of lower urinary tract symptoms on quality of life: the Leicester Impact Scale. Neurourol. Urodyn. 23, 229–236 (2004). · doi:10.1002/nau.20017

Cited by

See all 443

Metadata

Authors
Aoki, Y., Brown, H. W., Brubaker, L., Cornu, J. N., Daly, J. O., & Cartwright, R.
Venue
Nature Reviews Disease Primers
Published
2017-07-06
Volume
3
Issue
1
Pages
17042-17042
ISSN
2056-676X (ISSN-L)
OpenAlex
W2733089542
Cited by
443
References
148
FWCI
3.35
Type
journal article
Language
en
Open access
green
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.